Assessment of real-world application of advanced prostate cancer management in Japan

被引：0
作者：
Aragon-Ching, Jeanny B. [1 ,2 ]
机构：
[1] Inova Schar Canc Inst, GU Med Oncol, Fairfax, VA USA
[2] Univ Virginia, Dept Med, Charlottesville, VA USA
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2022年 / 11卷 / 12期
关键词：
Metastatic prostate cancer; prostate-specific membrane antigen-positron emission tomography scan (PSMA-PET scan); darolutamide; androgen deprivation therapy (ADT); bicalutamide; RISK;
D O I：
10.21037/tau-22-765
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：1614 / 1617
页数：4
相关论文
共 19 条
  • [1] [Anonymous], 2022, NCCN GUIDELINES VERS
  • [2] Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data
    Cheung, Stephane
    Hamuro, Yukinobu
    Mahlich, Joerg
    Nakayama, Masahiko
    Tsubota, Akiko
    [J]. PLOS ONE, 2018, 13 (04):
  • [3] More Unacceptable Denials: Now It's PSMA-Targeted PET/CT Imaging
    Czernin, Johannes
    Adams, Thaiza
    Calais, Jeremie
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (07) : 969 - 970
  • [4] Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference
    Fujita, Kazutoshi
    Suzuki, Hiroyoshi
    Hinata, Nobuyuki
    Miura, Yuji
    Edamura, Kohei
    Tabata, Ken-Ichi
    Arai, Gaku
    Matsubara, Nobuaki
    Yasumizu, Yota
    Kosaka, Takeo
    Oya, Mototsugu
    Sugimoto, Mikio
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, 11 (12) : 1771 - +
  • [5] Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
    Gillessena, Silke
    Attard, Gerhardt
    Beer, Tomasz M.
    Beltran, Himisha
    Bjartell, Anders
    Bossi, Alberto
    Briganti, Alberto
    Bristow, Rob G.
    Chi, Kim N.
    Clarke, Noel
    Davis, Ian D.
    de Bono, Johann
    Drake, Charles G.
    Duran, Ignacio
    Eeles, Ros
    Efstathiou, Eleni
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix Y.
    Fizazi, Karim
    Frydenberg, Mark
    Gleave, Martin
    Halabi, Susan
    Heidenreich, Axel
    Heinrich, Daniel
    Higano, Celestia S.
    Hofman, Michael S.
    Hussain, Maha
    James, Nicolas
    Kanesvaran, Ravindran
    Kantoff, Philip
    Khauli, Raja B.
    Leibowitz, Raya
    Logothetis, Chris
    Maluf, Fernando
    Millman, Robin
    Morgans, Alicia K.
    Morris, Michael J.
    Mottet, Nicolas
    Mrabti, Hind
    Murphy, Declan G.
    Murthy, Vedang
    Oh, William K.
    Ost, Piet
    OSullivan, Joe M.
    Padhani, Anwar R.
    Parker, Chris
    Poon, Darren M. C.
    Pritchard, Colin C.
    Reiter, Robert E.
    [J]. EUROPEAN UROLOGY, 2020, 77 (04) : 508 - 547
  • [6] Germline Variants of Prostate Cancer in Japanese Families
    Hayano, Takahide
    Matsui, Hiroshi
    Nakaoka, Hirofumi
    Ohtake, Nobuaki
    Hosomichi, Kazuyoshi
    Suzuki, Kazuhiro
    Inoue, Ituro
    [J]. PLOS ONE, 2016, 11 (10):
  • [7] Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
    Heath, Elisabeth, I
    Dyson, Gregory E.
    Cackowski, Frank C.
    Hafron, Jason
    Powell, Isaac
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : 524 - 532
  • [8] Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?
    Higano, Celestia
    [J]. NATURE REVIEWS UROLOGY, 2019, 16 (06) : 335 - 336
  • [9] A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer
    Lang, Shona H.
    Swift, Stephanie L.
    White, Heath
    Misso, Kate
    Kleijnen, Jos
    Quek, Ruben G. W.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (03) : 597 - 616
  • [10] With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer
    Madan, Ravi A.
    Mena, Esther
    Lindenberg, Liza
    Choyke, Peter L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (26) : 3015 - +
12